Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.
Qual é a melhor parte das suas compensações?
It is competitive with industry standards
O que você mais gosta nos lideres?
Open minded to alternative approaches and collaborative across functions
Quais são algumas das melhores coisas da sua equipe?
Very collaborative and talented group
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Coworkers are friendly and talented
O que está ruim e como pode melhorar?
Inconsistent goals and constantly shifting priorities by the day. Management rushes too much to push multiple objectives forward which results in work that often must be repeated or adjusted. More focus is needed to focus on a clear set of objectives.
Other Employee Reviews for Karyopharm Therapeutics
×